The most widely used diagnostic strategy for Lynch syndrome is based on selecting patients who fulfil the Amsterdam criteria [2] or any of the Revised Bethesda Guidelines [9], followed by Tumour (Tissue) Testing of MSI and/or immunostaining (IHC) of MMR proteins and germline mutation analysis in MMR deficient cases. The gene discussed is MRC1; the disease is neoplasm.